Side effects loom over Alzheimer’s drugs
The DOI matches its Crossref record.
Abstract
Despite landmark antibody approval, research into brain swelling and bleeding lags
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“All three have shown efficacy in clearing Aβ plaque and slowing cognitive decline, but the risks of amyloid-related imaging abnormalities (ARIA) and their treatment costs are noteworthy.422–424”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [424]
Citations
Cites
Still being checked.
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer's disease
Sang, Z., Huang, S., Tan, W., Ban, Y., Wang, K., Fan, Y., Chen, H., Zhang, Q., Liang, C., Mi, J., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.02.030 · Cited by 33
Amro, Z., Collins‐Praino, L. E., & Yool, A. J. (2024) · Bioscience Reports · doi:10.1042/bsr20231725 · Cited by 20
Stem cell therapy in Alzheimer’s disease: current status and perspectives
Ou, C.-M., Xue, W.-W., Liu, D., Ma, L., Xie, H.-T., & Ning, K. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1440334 · Cited by 19
Xie, Z., Situ, Y., Deng, L., Liang, M., Ding, H., Guo, Z., Xu, Q., Zhu, L., & Shao, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-88134-w · Cited by 19
Souchet, B., Michaïl, A., Billoir, B., & Braudeau, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417544 · Cited by 18
Insights from the neural guidance factor Netrin-1 into neurodegeneration and other diseases
Cai, M., Zheng, Q., Chen, Y., Liu, S., Zhu, H., & Bai, B. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1379726 · Cited by 16
Wei, X., Campagna, J. J., Jagodzinska, B. M., Wi, D., Cohn, W., Lee, J. T., Zhu, C., Huang, C., Molnár, L., Houser, C. R., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2400420121 · Cited by 15
Zhao, Y., Wu, K., Luo, W., Zhao, Y., Zeng, J., Wu, J., Yang, C., Yang, M., Liu, J., Lei, Z., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118071 · Cited by 13
Anti-amyloid treatments in Alzheimer’s disease: elegance, evidence and ethics
Daly, T. P., Olluri, A., & Kurkinen, M. T. (2024) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/198674 · Cited by 10
Regulation of the proteostasis network by the neuronal system
Zhu, H., & Cohen, E. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1290118 · Cited by 10
Huang, Q., Lv, Y. M., Ye, X. W., Xia, X., Chen, Y., Wang, X., Tong, F., Yang, W., Bozorov, K. A., Shevtsov, M. A., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114896 · Cited by 9
Neurostimulation devices to treat Alzheimer’s disease
Perez, F. P., Walker, B., Morisaki, J., Kanakri, H. M., & Rizkalla, M. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.100674 · Cited by 9
Anti‐amyloid treatments: Why we think they are worth it
Schindler, S. E., Musiek, E. S., & Morris, J. C. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70055 · Cited by 8
Taragano, F. E., Seinhart, D. B., Epstein, P., Sylvestre, V., Barañano, C., Castro, V. O., Sánchez, V., Kilstein, A., González, R., Franco‐Trecu, V., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251375430 · Cited by 6
Zeng, F., Li, H., Ma, Y., & Ma, S. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1600069 · Cited by 6
Communicating scientific evidence: drugs for Alzheimer’s disease as a case study
Kepp, K. P., Høilund‐Carlsen, P. F., Cristea, I. A., Cumming, R. G., Daly, T. P., Emilsson, L., Flacco, M. E., Hemkens, L. G., Janiaud, P., Johnsen, K. B., et al. (2025) · Current Medical Research and Opinion · doi:10.1080/03007995.2025.2458530 · Cited by 5
Perez, F. P., Morisaki, J., Kanakri, H. M., Rizkalla, M., & Abdalla, A. (2025) · IEEE Journal of Translational Engineering in Health and Medicine · doi:10.1109/jtehm.2025.3559693 · Cited by 5
Chiral Spindle-like Nanorods Reprogram Neuroinflammation by Catalyzing α-Ketoglutarate Biosynthesis
Dong, J., Xu, L., Xu, X., Shi, B., Wang, Q., Xu, J., Xu, C., Kuang, H., & Qu, A. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c19753 · Cited by 4
A short peptide protects from age‐onset proteotoxicity
Elsana, H., Bruck‐Haimson, R., Zhu, H., Siddiqui, A. A., Zaretsky, A., Cohen, I., Boocholez, H., Roitenberg, N., Moll, L., Plaschkes, I., et al. (2023) · Aging Cell · doi:10.1111/acel.14013 · Cited by 3
Denner, T. C., Heise, N. V., Zacharias, J., & Csük, R. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100139 · Cited by 3
Therapeutic Potential of Ishige okamurae Yendo as a Multi-Target Inhibitor Against Dementia Symptoms
Kwon, O. Y., & Lee, S. H. (2025) · Life · doi:10.3390/life15111699 · Cited by 2
Ethical Issues Around Treatment-Induced Amyloid-Related Imaging Abnormalities in Alzheimer's Disease
Daly, T. P. (2024) · Journal of Radiology Nursing · doi:10.1016/j.jradnu.2024.04.004 · Cited by 2
Liu, R., Ding, J., Zhong, L., & Lin, S. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250548 · Cited by 1
Characterization of the Anti-Alzheimer Drug Lecanemab by Mass Spectrometry
Sha, J., Geng, Z., Xue, S., Qi, S., Hu, Q., Hu, Q., Cai, M., Chen, Y., Chen, Y., Liu, S., et al. (2026) · ACS Omega · doi:10.1021/acsomega.6c02666 · Cited by 1
A Novel Oxo‐Palmatine Derivative 2q as Potent Reversal Agents Against Alzheimer's Disease
Pang, S., Li, Z., Liu, A., Luo, Z., Yin, H., Fan, S., Shi, J., Liu, N., Pan, S., Yang, Y., et al. (2025) · Drug Development Research · doi:10.1002/ddr.70073 · Cited by 1
Proteomics for Novel Biomarker and Drug Target Discovery in Alzheimer Disease
Zhu, H., Cai, M., Chen, D., Sha, J., Du, L., Chen, Y., Liu, S., Zheng, Q., Wei, X., & Bai, B. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_12
tDCS improves early Alzheimer’s disease by synaptic vesicle fusion and release
Zhuang, Y.-Y., Yan, J., Wu, T.-C., Xu, W.-S., Wu, B. J., Xie, X., Wang, W.-J., Lin, H., Jian, J.-W., Wang, J.-Z., et al. (2026) · Military Medical Research · doi:10.1016/j.mmr.2026.100003
Wang, W., Wang, S., Zheng, Z., Cao, Y., Tan, M., Wang, J., Jian, J., Ding, Y., Chen, L. X., Hu, Z., et al. (2026) · Brain‐X · doi:10.1002/brx2.70049
Ma, X., Yuan, M., Gao, Y., Guo, Z., Liang, J., Yan, F.-X., Wang, S., Qiu, H., He, S., Li, Y., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-04983-w
Pal, T., Mukherjee, S., Karati, D., Pahari, N., Hossain, C. M., & Naskar, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815646126010017
Metadata
- Authors
- Couzin-Frankel, J.
- Corresponding author
- Couzin-Frankel, Jennifer
- Venue
- Science
- Published
- 2023-08-04
- Volume
- 381
- Issue
- 6657
- Pages
- 466-467
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4385516142
- Cited by
- 31
- References
- 0
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 8 · 2023: 4
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- Alzheimer's disease, adverse drug reactions, anti-amyloid antibodies, cerebral edema, intracranial hemorrhage, amyloid-beta
- MeSH terms
- Alzheimer Disease, Brain, Brain Edema, Humans, Thrombosis, Amyloid beta-Peptides, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.